arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

InfuSystem Holdings, Inc

INFU
$12.75 ▼ -0.36 (-2.75%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
68 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
70
Health
Good
Neutral
auto_awesome

Analytical Summary

InfuSystem Holdings, Inc shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $255.9M
Dividend Yield —
Revenue Growth 2.6% ↗
Op. Margin 11.2% ↗
ROIC 4.4% ↗
FCF / Share $0.33 ↗
Trailing P/E 79.7x
Price / Book 4.3x
FCF Yield 2.6%
Debt / Equity 0.35
info Valuation on last close. End-of-day price, Sep 23, 2026.

68-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$36.93M
↑ +2.6% —
Net Income Profit after all expenses
$3.23M
↑ +24.3% —
Operating Margin Operating profit as % of sales
11.2%
↑ +138.2% 52th
FCF / Share Free cash flow per share
$0.33
↑ +728.1% —
Long-Term Debt Long-term obligations
$20.42M
↑ +4.0% —

Health Breakdown

Profitability ↑
59
Returns ↑
72
Financial Health →
71
Cash Quality ↓
93

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 18 years · 68 quarters